← FDA Drug Approvals (Drugs@FDA)

VYALEV

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2024-10-16

Drug application

FDA Application #

NDA216962

Application type

New Drug Application

Brand name

VYALEV

Generic name

FOSCARBIDOPA/FOSLEVODOPA

Active ingredients

FOSCARBIDOPA; FOSLEVODOPA

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

AbbVie Inc.

First approval

2024-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown